EVOQ Therapeutics
Business Services · Michigan, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1600 Huron Pkwy Fl 2 Bldg 420, Ann Arbor...Phone Number
(734) 769-1110Website
www.evoqtherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About EVOQ Therapeutics
Founded in 2016 and headquartered in Ann Arbor, Michigan, EVOQ Therapeutics is advancing a pipeline of disease-specific immune modulators to treat patients afflicted with autoimmune diseases. EVOQ's technology platform utilizes a proprietary NanoDisc that has been optimized to deliver antigens to restore immune tolerance.Explore more
EVOQ Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is EVOQ Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if EVOQ Therapeutics is spiking on competitors!
Earning: See what the market has to say on EVOQ Therapeutics recently announced quarterly report
EVOQ Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when EVOQ Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at EVOQ Therapeutics
Check if EVOQ Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if EVOQ Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once EVOQ Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined EVOQ Therapeutics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
EVOQ Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
EVOQ Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about EVOQ Therapeutics.
EVOQ Therapeutics financials insights
Gather financial insights about EVOQ Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Grant
$2M
EVOQ Therapeutics Tech Stack
A closer look at the technologies used by EVOQ Therapeutics
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Project
Product Development, Research & Development, Intellectual Property, Legal Affairs, Medical Research, Healthcare Technology
Person-Based
Funding
Funding
Funding
Project
Laboratory Operations, Medical Research, Operations
EVOQ Therapeutics News & Media
EVOQ Therapeutics Awarded $2 Million NIH Grant to Advance Therapies to Treat Celiac Disease - An Autoimmune Disease Impacting 2.4 Million Americans
ANN ARBOR, Mich. and CHICAGO, Oct. 14, 2025 /PRNewswire/ -- EVOQ Therapeutics, Inc. (EVOQ) a biopharmaceutical company dedicated to the treatment of autoimmune diseases, announced today the receipt of a $2 million grant from the National Institutes of Health (NIH) to advance novel...EVOQ Therapeutics Secures $2 Million in Funding for Advanced Autoimmune NanoDisc Therapies
ANN ARBOR, Mich. and CHICAGO, Aug. 29, 2024 /PRNewswire/ -- EVOQ Therapeutics, Inc. (EVOQ) a biopharmaceutical company dedicated to the treatment of autoimmune diseases, announced today the receipt of a $2 million grant from the National Institutes of Health (NIH) to advance novel...EVOQ Therapeutics and Amgen Expanding Collaboration
- Milestone payment received, license and collaboration agreement expanded - ANN ARBOR, Mich., Jan. 18, 2023 /PRNewswire/ -- EVOQ Therapeutics today announced the advancement of their ongoing license and collaboration agreement with Amgen for the discovery and development of novel...EVOQ Therapeutics Expands Leadership Team with David Giljohann, Ph.D., as Chief Executive Officer and Greg Barrett as Chief Operating Officer
ANN ARBOR, Mich., Jan. 9, 2023 /PRNewswire/ -- EVOQ Therapeutics, Inc. (EVOQ), a biopharmaceutical company focused on the discovery and development of drugs to treat patients afflicted with autoimmune diseases, today announced the appointment of David Giljohann, Ph.D., as Chief Executive...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding EVOQ Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2016 and headquartered in Ann Arbor, Michigan, EVOQ Therapeutics is advancing a pipeline of disease-specific immune modulators to treat patients afflicted with autoimmune diseases. EVOQ's technology platform utilizes a proprietary NanoDisc that has been optimized to deliver antigens to restore immune tolerance.... Read More
